A developer of minimally invasive cancer therapies, Rita Medical Systems, has signed a copromotion agreement with Aloka, a Japanese maker of diagnostic ultrasound equipment. Under
A developer of minimally invasive cancer therapies, Rita Medical Systems, has signed a copromotion agreement with Aloka, a Japanese maker of diagnostic ultrasound equipment. Under terms of the agreement, each company's U.S. sales force will be trained in the others' products to help identify potential common customers. The two companies will also cooperate on formal physician training programs, cosponsor trade show receptions, and display products and promotional materials at each other's booths at industry shows and conferences. Each company will retain direct control of the sales process for its respective products. Ultrasound is often used to visualize and guide the placement of Rita's radio-frequency ablation devices.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.